Patents by Inventor Hiroji Iwata

Hiroji Iwata has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8865663
    Abstract: An administration method comprising: determining a cancer type through (i) first data indicating that an Estrogen Receptor (ER) is negative and a Human Epidermal growth factor Receptor-2 (Her2) is negative, or (ii) second data indicating that at least one of the ER and the Her2 is positive; and when the cancer type is determined through (i) the first data indicating that the ER is negative and the Her2 is negative: first performing a docetaxel administration cycle comprising administrating docetaxel to a patient multiple times at certain intervals; and then performing a 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) administration cycle comprising administrating 5-fluorouracil, epirubicin, and cyclophosphamide to the patient multiple times at certain intervals, and when the cancer type is determined through (ii) the second data indicating that at least one of the ER and Her2 is positive: first performing the FEC administration cycle; and then performing the docetaxel administration cycle.
    Type: Grant
    Filed: January 26, 2009
    Date of Patent: October 21, 2014
    Assignee: Japan Breast Cancer Research Group
    Inventors: Masakazu Toi, Hiroji Iwata, Katsumasa Kuroi, Seigo Nakamura, Shinji Ohno, Norikazu Masuda, Kenjiro Aogi, Nobuaki Sato, Futoshi Akiyama, Masafumi Kurosumi, Hitoshi Tsuda
  • Publication number: 20110015144
    Abstract: There was no device that proposes a method for administrating anti-cancer drugs according to each of cancer types. An administration method proposing device (100) includes an input unit (101) that receives an input of the cancer type of a cancer patient, an administration procedure determination unit (102) that determines the administration order of an FEC (F: 5-fluorouracil, E: epirubicin, and C: cyclophosphamide) administration cycle and a docetaxel administration cycle, and a display unit (103) that displays the administration order of the FEC administration cycle and the docetaxel administration cycle, as a result of the determination by the administration procedure determination unit (102).
    Type: Application
    Filed: January 26, 2009
    Publication date: January 20, 2011
    Inventors: Masakazu Toi, Hiroji Iwata, Katsumasa Kuroi, Seigo Nakamura, Shinji Ohno, Norikazu Masuda, Kenjiro Aogi, Nobuaki Sato, Futoshi Akiyama, Masafumi Kurosumi, Hitoshi Tsuda
  • Patent number: 6521890
    Abstract: When SIM image data D[n] of a mark is compared with reference SIM image data in calculating a displacement of machining position in the nth time, image data D[n−1] just before the nth time is employed as the reference image data and a position displacement of the image is obtained from matching processing of the two kinds of image data of D[n] and D[n−1] to calculate a displacement of machining position.
    Type: Grant
    Filed: July 1, 1999
    Date of Patent: February 18, 2003
    Assignee: Hitachi, Ltd.
    Inventors: Tohru Ishitani, Tsuyoshi Ohnishi, Megumi Aizawa, Hiroji Iwata
  • Publication number: 20020092985
    Abstract: When SIM image data D[n] of a mark is compared with reference SIM image data in calculating a displacement of machining position in the nth time, image data D[n−1] just before the nth time is employed as the reference image data and a position displacement of the image is obtained from matching processing of the two kinds of image data of D[n] and D[n−1] to calculate a displacement of machining position.
    Type: Application
    Filed: July 1, 1999
    Publication date: July 18, 2002
    Inventors: TOHRU ISHITANI, TSUYOSHI OHNISHI, MEGUMI AIZAWA, HIROJI IWATA